Reporting by Aditi Shah Editing by David GoodmanOur Standards: The Thomson Reuters Trust Principles. Reporting by Sachin Ravikumar in Bengaluru; Editing by Subhranshu SahuOur Standards: The Thomson Reuters Trust Principles. "Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network." India on Tuesday reported its worst daily death toll of the pandemic and has large parts of the country under lockdown in an effort to counter an accelerating second wave of infections. read more"We expect intermittent supplies (of tocilizumab) as demand outstrips supply," Cipla said.
India is under lockdown due to the deadly infection of Covid.
( z0 lock-down :ARG1 ( z1 country :name ( z2 name :op "India" ) ) :ARG1-of ( z3 cause :ARG0 ( z4 infect :ARG0-of ( z5 kill ) :ARG1 ( z6 product :name ( z7 name :op "Covid" ) ) ) ) )
(z0 / lock-down-06
    :ARG1 (z1 / country
              :name (z2 / name
                        :op1 "India"))
    :ARG1-of (z3 / cause-01
                 :ARG0 (z4 / infect-01
                           :ARG0-of (z5 / kill-01)
                           :ARG1 (z6 / product
                                     :name (z7 / name
                                               :op1 "Covid")))))
India is under lockdown due to the deadly infection of Covid .
z1 :name z2
z2 :op1 1
z0 :ARG1 z1
z0 :ARG1-of z3
z4 :ARG0-of z5
z3 :ARG0 z4
z4 :ARG1 z6
z6 :name z7
z7 :op1 0